December 8, 2021
RegMed Investors’ (RMi) pre-open: quick and hi-higher highs; say bye
December 7, 2021
RegMed Investors’ (RMi) pre-open: the cell and gene therapy sector is not through correcting
December 6, 2021
RegMed Investors’ (RMi) pre-open: lean pickings
December 3, 2021
RegMed Investors’ (RMi) pre-open: a pre-occupied week
December 2, 2021
RegMed Investors’ (RMi) pre-open: bounce-back
December 1, 2021
RegMed Investors’ (RMi) pre-open: what went down, does come back up
November 30, 2021
RegMed Investors’ (RMi) pre-open: it ain’t over, investors are wary of buying dips as electronic trading contracts and controls share pricing
November 29, 2021
RegMed Investors’ (RMi) pre-open: will futures moves drive a sustainable sector response
November 26, 2021
RegMed Investors’ (RMi) pre-open: a Red versus a Black Friday while a new covid variant surfaces
November 24, 2021
RegMed Investors’ (RMi) pre-open: Happy Thanksgiving, got to go
November 23, 2021
RegMed Investors’ (RMi) pre-open: weighing the risks of low volume and a shortened week while catalysts aren’t apparent
November 22, 2021
RegMed Investors’ (RMi) pre-open: if going to sell, wait for a strengthening
November 19, 2021
RegMed Investors’ (RMi) pre-open: sector pullbacks – ups, downs and a maybe?
November 18, 2021
RegMed Investors’ (RMi) pre-open: concerns about risk
November 17, 2021
RegMed Investors’ (RMi) pre-open: what’s to see today – a fog surrounds sector equities
November 16, 2021
RegMed Investors’ (RMi) pre-open: the sector’s eight (8) session stumble
November 15, 2021
RegMed Investors’ (RMi) pre-open: After last week's market losses, how should investors respond?
November 12, 2021
RegMed Investors’ (RMi) pre-open: another quick exit Friday after six (6) negative closes?
November 11, 2021
RegMed Investors’ (RMi) pre-open: a weak aftermarket underwhelms expectation
November 10, 2021
RegMed Investors’ (RMi) pre-open: sector weakness should/could unfold some of the oversold
November 9, 2021
RegMed Investors’ (RMi) pre-open: a sector retreat is not a defeat, it will just move directionally
November 8, 2021
RegMed Investors’ (RMi) pre-open: "Skip to My (The) Lou" after a record close, a sector decline, more LPS (loss-per-share) earnings this week
November 5, 2021
RegMed Investors’ (RMi) pre-open: not so fast to the sector exit on Friday but, I'm still walking instead of running
November 4, 2021
RegMed Investors’ (RMi) pre-open: there are sessions I am out-on-the-limb having brought a saw with me
November 3, 2021
RegMed Investors’ (RMi) pre-open: is today, a post earnings response and some more
1 hour 25 min ago
RegMed Investors’ (RMi) pre-open: quick and hi-higher highs; say bye
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2021 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.